A 6-week, randomized, multicentre, open-label study comparing efficacy and tolerability of amisulpride at a starting dose of 400 mg/day versus 800 mg/day in patients with acute exacerbations of schizophrenia.
about
A 6-week, randomized, multicentre, open-label study comparing efficacy and tolerability of amisulpride at a starting dose of 400 mg/day versus 800 mg/day in patients with acute exacerbations of schizophrenia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
A 6-week, randomized, multicen ...... xacerbations of schizophrenia.
@en
A 6-week, randomized, multicen ...... xacerbations of schizophrenia.
@nl
type
label
A 6-week, randomized, multicen ...... xacerbations of schizophrenia.
@en
A 6-week, randomized, multicen ...... xacerbations of schizophrenia.
@nl
prefLabel
A 6-week, randomized, multicen ...... xacerbations of schizophrenia.
@en
A 6-week, randomized, multicen ...... xacerbations of schizophrenia.
@nl
P2093
P2860
P1476
A 6-week, randomized, multicen ...... xacerbations of schizophrenia.
@en
P2093
Bon Hoon Koo
Jong Hun Lee
Kwang Hun Lee
Seung Jae Lee
Sung Won Jung
Tae Young Choi
P2860
P304
P356
10.1007/S40261-012-0002-8
P577
2012-11-01T00:00:00Z